Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 42.70
-0.10 (-0.23%)
Jun 27, 2025, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 5.51 billion as of June 27, 2025. Its market cap has decreased by -44.01% in one year.
Market Cap
5.51B
Enterprise Value
4.19B
Revenue
167.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.70
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 5.51B, an increase of 13.46%. That is a compound annual growth rate of 3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 5.52B | -19.09% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 190.00B |
| PharmaEssentia | 181.63B |
| Bora Pharmaceuticals Co., LTD. | 84.20B |
| Lotus Pharmaceutical | 57.58B |
| Oneness Biotech | 31.37B |
| Polaris Group | 29.47B |
| Center Laboratories | 27.35B |
| Lumosa Therapeutics | 25.66B |